Back to top

messenger-rna: Archive

Zacks Equity Research

Moderna (MRNA), Merck Start 2nd Late-Study on Cancer Therapy

The second late-stage study will evaluate Moderna (MRNA)/Merck's investigational cancer combination therapy in certain lung cancer patients. A late-stage study in melanoma indication is ongoing.

NVOPositive Net Change MRKPositive Net Change MRNANegative Net Change CTMXNegative Net Change